186 related articles for article (PubMed ID: 36932691)
1. Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
Mas-Peiro S; Abplanalp WT; Rasper T; Berkowitsch A; Leistner DM; Dimmeler S; Zeiher AM
Eur Heart J; 2023 Jun; 44(21):1943-1952. PubMed ID: 36932691
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesicles.
Hosen MR; Goody PR; Zietzer A; Xiang X; Niepmann ST; Sedaghat A; Tiyerili V; Chennupati R; Moore JB; Boon RA; Uchida S; Sinning JM; Zimmer S; Latz E; Werner N; Nickenig G; Jansen F
Circulation; 2022 Dec; 146(24):1836-1854. PubMed ID: 35862223
[TBL] [Abstract][Full Text] [Related]
3. Long-term risk associated with clonal hematopoiesis in patients with severe aortic valve stenosis undergoing TAVR.
Mas-Peiro S; Pergola G; Berkowitsch A; Meggendorfer M; Rieger MA; Vasa-Nicotera M; Dimmeler S; Zeiher AM
Clin Res Cardiol; 2023 May; 112(5):585-593. PubMed ID: 36680616
[TBL] [Abstract][Full Text] [Related]
4. Left atrial function index (LAFI) and outcome in patients undergoing transcatheter aortic valve replacement.
Shamekhi J; Nguyen TQA; Sigel H; Maier O; Piayda K; Zeus T; Al-Kassou B; Weber M; Zimmer S; Sugiura A; Wilde N; Kelm M; Nickenig G; Veulemans V; Sedaghat A
Clin Res Cardiol; 2022 Aug; 111(8):944-954. PubMed ID: 35320406
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement.
Yesiltas MA; Haberal İ; Kuserli Y; Yildiz A; Koyuncu AO; Özsoy SD
Heart Surg Forum; 2020 Apr; 23(2):E212-E220. PubMed ID: 32364917
[TBL] [Abstract][Full Text] [Related]
6. Short-Term and Long-Term Outcomes of Patients Undergoing Urgent Transcatheter Aortic Valve Replacement Under a Minimalist Strategy.
Ichibori Y; Li J; Patel T; Lipinski J; Ladas T; Saric P; Kobe D; Tsushima T; Peters M; Patel S; Davis A; Markowitz AH; Bezerra HG; Costa MA; Kalra A; Attizzani GF
J Invasive Cardiol; 2019 Feb; 31(2):E30-E36. PubMed ID: 30700628
[TBL] [Abstract][Full Text] [Related]
7. Validation of STS/ACC TVT-TAVR Score in Veterans Undergoing Transcatheter Aortic Valve Replacement.
Reiff C; Gurevich S; Bertog S; Sorajja P; Kelly R; Garcia S
J Invasive Cardiol; 2018 Dec; 30(12):447-451. PubMed ID: 30218556
[TBL] [Abstract][Full Text] [Related]
8. The impact of mitral stenosis on outcomes of aortic valve stenosis patient undergoing surgical aortic valve replacement or transcatheter aortic valve replacement.
Al-Khadra Y; Darmoch F; Baibars M; Kaki A; Fanari Z; Alraies MC
J Interv Cardiol; 2018 Oct; 31(5):655-660. PubMed ID: 29774601
[TBL] [Abstract][Full Text] [Related]
9. Discongruence Index - Simple Indicator to Predict Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement.
de Agustin JA; Islas F; Jimenez-Quevedo P; Nombela-Franco L; Rueda Liñares A; Mahia P; Marcos-Alberca P; Pozo E; Gomez de Diego JJ; Luaces M; Nuñez-Gil IJ; Garcia-Fernandez MÁ; Fernandez-Ortiz A; Macaya C; Perez de Isla L
Circ J; 2018 Oct; 82(11):2880-2886. PubMed ID: 30135324
[TBL] [Abstract][Full Text] [Related]
10. Energy loss index as a predictor of all-cause mortality after transcatheter aortic valve replacement: A long-term follow-up.
Johal G; Jonnala V; Pourafkari L; Sedghi S; Jafarsis S; Fernandez S; Iyer V; Nader ND
Echocardiography; 2023 Apr; 40(4):327-334. PubMed ID: 36859692
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.
Joseph L; Bashir M; Xiang Q; Yerokun BA; Matsouaka RA; Vemulapalli S; Kapadia S; Cigarroa JE; Zahr F
JACC Cardiovasc Interv; 2018 Apr; 11(7):693-702. PubMed ID: 29622149
[TBL] [Abstract][Full Text] [Related]
12. Outcome of Patients with Low-Gradient Aortic Stenosis Undergoing Transcatheter or Surgical Aortic Valve Replacement.
Kugelman N; Jaffe R; Aronson D; Sharoni E; Adawi S; Khader N; Shiran A
Cardiovasc Revasc Med; 2020 Mar; 21(3):257-262. PubMed ID: 31103371
[TBL] [Abstract][Full Text] [Related]
13. Ten-year experience with transcatheter and surgical aortic valve replacement in Finland.
Mäkikallio T; Jalava MP; Husso A; Virtanen M; Laakso T; Ahvenvaara T; Tauriainen T; Maaranen P; Kinnunen EM; Dahlbacka S; Jaakkola J; Airaksinen J; Anttila V; Savontaus M; Laine M; Juvonen T; Valtola A; Raivio P; Eskola M; Niemelä M; Biancari F
Ann Med; 2019; 51(3-4):270-279. PubMed ID: 31112060
[No Abstract] [Full Text] [Related]
14. Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: FDA Patient-Level Meta-Analysis of Premarket Clinical Trials.
Zusterzeel R; Mishra NK; Beydoun H; Laschinger J; Wu C; Dong LM; Lin JA; Marinac-Dabic D; Strauss DG; Caños DA
J Womens Health (Larchmt); 2018 Jun; 27(6):808-814. PubMed ID: 29741978
[TBL] [Abstract][Full Text] [Related]
15. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry.
Hira RS; Vemulapalli S; Li Z; McCabe JM; Rumsfeld JS; Kapadia SR; Alam M; Jneid H; Don C; Reisman M; Virani SS; Kleiman NS
JAMA Cardiol; 2017 Aug; 2(8):846-854. PubMed ID: 28636718
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of the Fibrosis-4 index in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Sudo M; Shamekhi J; Sedaghat A; Aksoy A; Zietzer A; Tanaka T; Wilde N; Weber M; Sinning JM; Grube E; Veulemans V; Adam M; Kelm M; Baldus S; Nickenig G; Zimmer S; Tiyerili V; Al-Kassou B
Clin Res Cardiol; 2022 Dec; 111(12):1367-1376. PubMed ID: 35852581
[TBL] [Abstract][Full Text] [Related]
17. The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States.
Brennan JM; Holmes DR; Sherwood MW; Edwards FH; Carroll JD; Grover FL; Tuzcu EM; Thourani V; Brindis RG; Shahian DM; Svensson LG; O'Brien SM; Shewan CM; Hewitt K; Gammie JS; Rumsfeld JS; Peterson ED; Mack MJ
Ann Thorac Surg; 2014 Dec; 98(6):2016-22; discussion 2022. PubMed ID: 25443009
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis.
Landes U; Iakobishvili Z; Vronsky D; Zusman O; Barsheshet A; Jaffe R; Jubran A; Yoon SH; Makkar RR; Taramasso M; Russo M; Maisano F; Sinning JM; Shamekhi J; Biasco L; Pedrazzini G; Moccetti M; Latib A; Pagnesi M; Colombo A; Tamburino C; D' Arrigo P; Windecker S; Pilgrim T; Tchetche D; De Biase C; Guerrero M; Iftikhar O; Bosmans J; Bedzra E; Dvir D; Mylotte D; Sievert H; Watanabe Y; Søndergaard L; Dagnegård H; Codner P; Kodali S; Leon M; Kornowski R
JACC Cardiovasc Interv; 2019 Jan; 12(1):78-86. PubMed ID: 30621982
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-Analysis.
Saad M; Nairooz R; Pothineni NVK; Almomani A; Kovelamudi S; Sardar P; Katz M; Abdel-Wahab M; Bangalore S; Kleiman NS; Block PC; Abbott JD
JACC Cardiovasc Interv; 2018 Jan; 11(1):24-35. PubMed ID: 29055767
[TBL] [Abstract][Full Text] [Related]
20. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
Abdelghani M; Abdel-Wahab M; Hemetsberger R; Landt M; Merten C; Toelg R; Richardt G
Int J Cardiol; 2019 Aug; 288():39-43. PubMed ID: 30948219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
